Structural design of tetravalent T-cell engaging bispecific antibodies: improve developability by engineering disulfide bonds
Abstract Since the advances in protein engineering and manufacture, over the last 30 years, antibody-based immunotherapeutic has become a powerful strategy to treat diseases. The T-cell engaging bispecific antibody (BsAb) by combining the Fab binding domain of tumor antigens and Fab or single-chain...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2021-06-01
|
| Edice: | Journal of Biological Engineering |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s13036-021-00272-7 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
